Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
AstraZeneca
Chinese Patent Office
Baxter
McKinsey
Fish and Richardson
Daiichi Sankyo
US Department of Justice
UBS

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Molybdenum

« Back to Dashboard

US Patents for Molybdenum

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molybdenum ➤ Sign Up Overbased additives for lubricant oils containing a molybdenum complex, process for preparing them and compositions containing the said additives Societe Nationale Elf Aquitaine (Courbevoie, FR) ➤ Sign Up
Molybdenum ➤ Sign Up Hydrodealkylation of C9+ aromatic compounds Phillips Petroleum Company (Bartlesville, OK) ➤ Sign Up
Molybdenum ➤ Sign Up Hydrodealkylation of C.sub.9 + aromatic compounds Phillips Petroleum Company (Bartlesville, OK) ➤ Sign Up
Molybdenum ➤ Sign Up Catalysts made from transition metal compounds and 4, 5-diphosphinoacridine-ligands Studiengesellschaft Kohle mbH (Mulheim an der Ruhr, DE) ➤ Sign Up
Molybdenum ➤ Sign Up 2-phenyl benzimidazole derivatives as MCP-1 antagonists Millennium Pharmaceuticals, Inc. (Cambridge, MA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Molybdenum

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Molybdenum Germany 69004163 2009-06-19 ➤ Sign Up
Molybdenum European Patent Office 0404650 2009-06-19 ➤ Sign Up
Molybdenum Spain 2060977 2009-06-19 ➤ Sign Up
Molybdenum France 2648473 2009-06-19 ➤ Sign Up
Molybdenum Japan 2883167 2009-06-19 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Dow
Baxter
Moodys
Covington
Daiichi Sankyo
McKesson
Cerilliant
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: